Related Experiment Videos

Is Haemophilus influenzae type b disease finished?

Dominic Kelly¹, E Richard Moxon

¹Department of Pediatrics, University of Oxford, United Kingdom.

Advances in Experimental Medicine and Biology

|July 15, 2004

Summary

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Studying Early Life Live-Attenuated influenza virus immune Responses (STELLAR): study protocol for an exploratory observational study of the nasal mucosal and systemic immune response in healthy children given an intranasal live-attenuated influenza vaccine.

BMJ open·2026

Immunogenicity, reactogenicity, and safety of a reduced-interval 4CMenB primary immunisation schedule in UK infants: a multicentre, open-label, assessor-blinded, phase 4 randomised controlled trial.

The Lancet. Infectious diseases·2026

Optimising DTwP-containing vaccine infant immunisation schedules in Uganda and Nepal (OptImms): two open-label, non-inferiority, randomised controlled trials.

The Lancet. Infectious diseases·2026

Prior immunological memory to pertussis toxin affects the avidity development of anti-PT IgG antibodies after acellular pertussis booster vaccination.

Emerging microbes & infections·2025

The effect of pertussis vaccination in pregnancy on the immunogenicity of acellular or whole-cell pertussis vaccination in Gambian infants (GaPS): a single-centre, randomised, controlled, double-blind, phase 4 trial.

The Lancet. Infectious diseases·2025

A novel whole blood assay to quantify the release of T cell associated cytokines in response to Bordetella pertussis antigens.

Journal of immunological methods·2024

See all related articles